Management of Hypertension and Coronary Artery Disease with Amlodipine
Introduction to Amlodipine Therapy
- Dihydropyridine calcium channel blockers like amlodipine are considered appropriate drugs of choice for patients with stable angina and coronary artery disease, according to the American Heart Association 1, 2
- In patients with hypertension and stable coronary artery disease, dihydropyridine CCBs can be added to the basic regimen of β-blocker, ACE inhibitor, and thiazide diuretic if either angina or hypertension remains uncontrolled, as recommended by the American College of Cardiology 2
Recommended Treatment Approach
- First-line therapy should include a β-blocker (especially with prior myocardial infarction), ACE inhibitor or ARB (particularly with prior myocardial infarction, left ventricular dysfunction, diabetes, or chronic kidney disease), and thiazide or thiazide-like diuretic, as suggested by the American Heart Association 2
- If blood pressure remains uncontrolled, adding a long-acting dihydropyridine CCB like amlodipine at appropriate dosing (5-10mg once daily) is recommended by the American College of Cardiology 2
Blood Pressure Targets and Management
- For patients with coronary artery disease, the target blood pressure is <140/90 mmHg (Class IIa; Level of Evidence B), according to the American Heart Association 4
- A lower target (<130/80 mmHg) may be considered in some individuals with coronary artery disease, previous stroke, or coronary artery disease risk equivalents (Class IIb; Level of Evidence B), as recommended by the American College of Cardiology 4
- Combining non-dihydropyridine CCBs with β-blockers should be used with caution due to increased risk of bradyarrhythmias and heart failure, as noted by the American Heart Association 2
Special Considerations in Patient Management
- In patients with heart failure and reduced ejection fraction, non-dihydropyridine CCBs (verapamil and diltiazem) should be avoided, according to the American College of Cardiology 5
- For patients with hypertension and heart failure with preserved ejection fraction, dihydropyridine CCBs may be effective to minimize symptoms, as suggested by the American Heart Association 5
- In elderly patients, monitoring for orthostatic changes and avoiding excessively low diastolic blood pressure (<65 mmHg) is recommended by the American Geriatrics Society 6